Saba Capital Management, L.P. has made a notable move by acquiring additional shares in Gabelli Healthcare & WellnessRx Trust. This acquisition, reported in a recent SEC filing, is significant as it highlights Saba's continued commitment to investing in the healthcare sector.

According to the SEC filing dated October 30, 2026, Saba Capital Management acquired 500 shares of Gabelli Healthcare & WellnessRx Trust on October 29, 2026, at a price of $10.09 per share. Following this transaction, Saba now owns a total of 2,174,625 shares of the trust. This increase in ownership is indicative of Saba's strategy to bolster its investment portfolio in the healthcare industry.

Background

Saba Capital Management, L.P. is an investment management firm based in New York, incorporated in Delaware. The firm primarily focuses on managing funds and accounts, with a strong emphasis on strategic investments in various sectors, including healthcare. The company has been active in the market, as evidenced by multiple recent filings, including several Form 4 submissions on October 30, 2026.

What the Filing Says

The filing states, "Saba Capital Management, L.P. acquired 500 shares of Gabelli Healthcare & WellnessRx Trust on October 29, 2026, at a price of $10.09 per share." This acquisition reflects Saba's ongoing investment strategy and its belief in the potential of the healthcare sector.

Impact

This acquisition may impact various stakeholders, including current and prospective investors in Gabelli Healthcare & WellnessRx Trust. Saba's increased stake could signal confidence in the trust's future performance, potentially influencing market sentiment and investment decisions in the healthcare sector.

What's Next

The filing does not say what happens next. However, Saba Capital Management's ongoing activity in the market suggests that further transactions or strategic moves may be forthcoming as they continue to manage their investment portfolio.